Two decades of research has Australian scientists on the path to diagnosing aggressive forms of prostate cancer before it's too late.
The painstaking discovery of new epigenetic biomarkers, or DNA features associated with abnormal cell division, is the work of senior staff at Sydney's Garvan Institute.
